Host-pathogen interactions and the pathogenesis of murine Lyme disease.

Lyme disease results from persistent infection with the spirochete Borrelia burgdorferi. A combination of bacterial factors and host factors contributes to the development of inflammatory disease. Studies from the past year have provided insight into both sides of this host-pathogen interplay. We now have a better appreciation of the bacterial genes and products that are involved in pathology and the components of the host response that participate in disease development.

[1]  S. Telford,et al.  Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions. , 1995, The Journal of infectious diseases.

[2]  G. Wormser,et al.  Impact of Genotypic Variation of Borrelia burgdorferi Sensu Stricto on Kinetics of Dissemination and Severity of Disease in C3H/HeJ Mice , 2001, Infection and Immunity.

[3]  U. Schaible,et al.  Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. , 1994, International immunology.

[4]  Charles R. Brown,et al.  Genes outside the major histocompatibility complex control resistance and susceptibility to experimental Lyme arthritis , 2000, Medical Microbiology and Immunology.

[5]  D. Persing,et al.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. , 1991, The American journal of pathology.

[6]  E. Fikrig,et al.  Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  T. Schwan,et al.  Variable small protein (Vsp)‐dependent and Vsp‐independent pathways for glycosaminoglycan recognition by relapsing fever spirochaetes , 2000, Molecular microbiology.

[8]  A. Hayday,et al.  CD4+ T Helper 1 Cells Facilitate Regression of Murine Lyme Carditis , 2001, Infection and Immunity.

[9]  Charles R. Brown,et al.  Experimental Lyme Arthritis in the Absence of Interleukin-4 or Gamma Interferon , 1999, Infection and Immunity.

[10]  C. Teuscher,et al.  Interleukin-4 (IL-4) and IL-13 Signaling Pathways Do Not RegulateBorrelia burgdorferi-Induced Arthritis in Mice: IgG1 Is Not Required for Host Control of Tissue Spirochetes , 2000, Infection and Immunity.

[11]  R. M. Wooten,et al.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. , 1999, Journal of immunology.

[12]  A. Steere,et al.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. , 1998, Science.

[13]  E. Fikrig,et al.  Borrelia burgdorferi Gene Expression In Vivo and Spirochete Pathogenicity , 2000, Infection and Immunity.

[14]  J. A. Carroll,et al.  Effects of Environmental pH on Membrane Proteins in Borrelia burgdorferi , 1999, Infection and Immunity.

[15]  J. A. Carroll,et al.  Distinct Regulatory Pathways Control Expression ofBorrelia burgdorferi Infection-Associated OspC and Erp Surface Proteins , 2001, Infection and Immunity.

[16]  B. S. Schneider,et al.  An analysis of spirochete load, strain, and pathology in a model of tick-transmitted Lyme borreliosis. , 2001, Vector borne and zoonotic diseases.

[17]  B. P. Guo,et al.  Resistance to Lyme disease in decorin-deficient mice. , 2001, The Journal of clinical investigation.

[18]  S. Akira,et al.  Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.

[19]  L. Sigal.  Lyme disease: a review of aspects of its immunology and immunopathogenesis. , 1997, Annual review of immunology.

[20]  J. Leong,et al.  Identification of a candidate glycosaminoglycan‐binding adhesin of the Lyme disease spirochete Borrelia burgdorferi , 2000, Molecular microbiology.

[21]  S. Barthold,et al.  Lyme borreliosis in selected strains and ages of laboratory mice. , 1990, The Journal of infectious diseases.

[22]  E. Fikrig,et al.  Borrelia burgdorferi genes selectively expressed in the infected host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Bono,et al.  Altered Stationary-Phase Response in aBorrelia burgdorferi rpoS Mutant , 2000, Journal of bacteriology.

[24]  P. Godowski,et al.  Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. , 1999, Science.

[25]  D. Golenbock,et al.  Toll-like Receptor 2 Functions as a Pattern Recognition Receptor for Diverse Bacterial Products* , 1999, The Journal of Biological Chemistry.

[26]  R. Doerge,et al.  Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses , 2001, Genes and Immunity.

[27]  W. Burgdorfer,et al.  Lyme disease-a tick-borne spirochetosis? , 1983, Science.

[28]  T. Schwan,et al.  Platelet activation by a relapsing fever spirochaete results in enhanced bacterium–platelet interaction via integrin αIIbβ3 activation , 2001, Molecular microbiology.

[29]  L. Glickstein,et al.  Gamma Interferon Is Not Required for Arthritis Resistance in the Murine Lyme Disease Model , 2001, Infection and Immunity.

[30]  J. Coburn,et al.  Delineation of Borrelia burgdorferi p66 Sequences Required for Integrin αIIbβ3 Recognition , 2001, Infection and Immunity.

[31]  B. Bloom,et al.  Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. , 1999, Science.

[32]  F. Cabello,et al.  Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN–RpoS regulatory pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Steere,et al.  The clinical evolution of Lyme arthritis. , 1987, Annals of internal medicine.

[34]  S. Norris,et al.  Correlation between plasmid content and infectivity in Borrelia burgdorferi. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Charles R. Brown,et al.  Bone-Marrow Chimeras Reveal Hemopoietic and Nonhemopoietic Control of Resistance to Experimental Lyme Arthritis1 , 2000, The Journal of Immunology.

[36]  J. Radolf,et al.  Regulation of OspE-Related, OspF-Related, and Elp Lipoproteins of Borrelia burgdorferi Strain 297 by Mammalian Host-Specific Signals , 2001, Infection and Immunity.

[37]  L. Bockenstedt,et al.  Passive immunizing activity of sera from mice infected with Borrelia burgdorferi , 1993, Infection and immunity.

[38]  R. M. Wooten,et al.  Toll-Like Receptor 2 Is Required for Innate, But Not Acquired, Host Defense to Borrelia burgdorferi1 , 2002, The Journal of Immunology.

[39]  B. P. Guo,et al.  Decorin‐binding adhesins from Borrelia burgdorferi , 1998, Molecular microbiology.

[40]  R. M. Wooten,et al.  Host-pathogen interactions promoting inflammatory Lyme arthritis: use of mouse models for dissection of disease processes. , 2001, Current opinion in microbiology.

[41]  T. Schwan,et al.  Temporal Changes in Outer Surface Proteins A and C of the Lyme Disease-Associated Spirochete, Borrelia burgdorferi, during the Chain of Infection in Ticks and Mice , 2000, Journal of Clinical Microbiology.

[42]  S. Barthold,et al.  Cutting Edge: T Cell-Mediated Pathology in Murine Lyme Borreliosis1 , 2000, The Journal of Immunology.

[43]  J. Ohnishi,et al.  Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  S. Norris,et al.  Analysis of Borrelia burgdorferivlsE Gene Expression and Recombination in the Tick Vector , 2001, Infection and Immunity.

[45]  S. Norris,et al.  Antigenic Variation in Lyme Disease Borreliae by Promiscuous Recombination of VMP-like Sequence Cassettes , 1997, Cell.

[46]  E. Fikrig,et al.  Borrelia burgdorferi-Induced Inflammation Facilitates Spirochete Adaptation and Variable Major Protein-Like Sequence Locus Recombination1 , 2001, The Journal of Immunology.

[47]  F. Liang,et al.  An Immune Evasion Mechanism for Spirochetal Persistence in Lyme Borreliosis , 2002, The Journal of experimental medicine.

[48]  E. Fikrig,et al.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA , 1990, Science.

[49]  S. Barthold,et al.  Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. , 1992, The American journal of tropical medicine and hygiene.

[50]  Maria Labandeira-Rey,et al.  Decreased Infectivity in Borrelia burgdorferi Strain B31 Is Associated with Loss of Linear Plasmid 25 or 28-1 , 2001, Infection and Immunity.

[51]  S. Norris,et al.  Kinetics and In Vivo Induction of Genetic Variation of vlsE in Borrelia burgdorferi , 1998, Infection and Immunity.

[52]  S. Barthold,et al.  T-Cell-Independent Responses to Borrelia burgdorferiAre Critical for Protective Immunity and Resolution of Lyme Disease , 2000, Infection and Immunity.